Skip to content
VitalScope
Editorially independent · No pharma or supplement advertising since 2017 · HONcode certified
Public Record · Maintained since 2017

Accountability · Editorial Record

The VitalScope Corrections Log

Every error we've issued since launch — original claim, corrected claim, who caught it, when it was resolved — published in real time, in plain English, with no paywall and no spin.

By the numbers

What the log actually shows.

1,180+ Corrections logged since the 2017 launch
96% Caught before any reader ever noticed
38min Average fact-check turnaround per article
9yrs Published continuously, with no gap years

Benchmarks verified against the Press Gazette 2023 health-publisher study. The first health publication to maintain a public corrections log of this scale.

Editor's note

Errors are inevitable. Hiding them is a choice.

Health journalism moves fast. New trials publish every week, drug labels shift, and a single misplaced decimal in a risk statistic can mislead a reader into skipping a vaccine or starting a supplement they don't need. At a publication that ships 28 to 35 articles a week, the honest answer is that we will sometimes get things wrong. What matters is what happens next.

VitalScope has published every correction in a public log since our first issue in 2017. Not a summary. Not a quarterly footnote. The full record — the original claim, the corrected claim, who flagged the error (a reader, an editor, a peer reviewer), and the timestamp of the resolution. We treat the log the way a hospital treats an incident report: as a working instrument, not a confession.

Every entry has been reviewed by at least one board-certified clinician from our 42-member Editorial Board before it appears here. Nothing is edited for comfort. If we overstated a benefit, we say so and link to the corrected version. If a citation was wrong, we link to the right one. If a reader caught it, we credit them by initials.

The pages below are searchable, filterable by topic, and downloadable as a structured feed for researchers and newsrooms. If you spot something we missed, write to the Editorial Standards Desk. We answer every report within one business day.

Recent entries

The log, as it stands this week.

Showing the 4 most recent of 1,184 entries · Sorted newest first · Updated at 06:00 ET

  1. "Daily multivitamin cuts cardiovascular events by 12%"

    Original claim A March 2026 brief summarized the COSMOS-Clinic substudy as showing a 12% reduction in major adverse cardiovascular events. Corrected claim The 12% figure refers to a secondary composite endpoint only; the primary endpoint (MACE) showed no statistically significant effect in the substudy population. Flagged by an external cardiologist on March 6; corrected version republished March 7, 06:14 ET.

    Caught by: Dr. R. M., board-certified cardiologist Read corrected article →
  2. GLP-1 agonist study sample size overstated

    Original claim Brief cited a JAMA meta-analysis as including 18,420 participants across 14 trials. Corrected claim The pooled cohort was 14,082 participants across 9 trials; the larger figure referenced a separate unpublished registry. Caught internally during routine PubMed cross-check.

    Caught by: Internal fact-check desk, 31 minutes after publication Read corrected article →
  3. SSRI discontinuation risk framing

    Original claim Article described SSRI withdrawal symptoms as "rare, affecting fewer than 1 in 50 patients." Corrected claim Recent systematic reviews estimate incidence between 15% and 40% depending on half-life and taper speed; we have revised language and added the cited review. Flagged by a reader and corroborated by an Editorial Board psychiatrist.

    Caught by: Reader S.K., corroborated by Editorial Board Read corrected article →
  4. Atrial fibrillation prevalence in adults under 40

    Original claim Brief reported AF prevalence in adults under 40 at "approximately 0.5%." Corrected claim Age-standardized prevalence is closer to 0.1%–0.2% in asymptomatic populations; the higher figure cited a symptomatic cohort and was not generalizable. Updated with CDC NHANES data.

    Caught by: Dr. A. P., electrophysiology fellow Read corrected article →
Browse all 1,184 entries Filterable by topic, date, and reporter · Exportable as CSV and JSON

The pipeline

How a flagged error becomes a public entry.

The 38-minute average turnaround is not a marketing line. It is an operational pipeline with four named stages, each owned by a specific role.

  1. 01

    Report received

    A reader, an Editorial Board clinician, or our internal cross-check flags a claim. Every report is logged into the Standards Desk queue within five minutes, regardless of source.

    Owner Editorial Standards Desk
  2. 02

    Source verification

    The flagged claim is checked against the original peer-reviewed paper, the FDA/EMA label, and a Cochrane Review where available. Citations are opened inline on the article itself.

    Owner Fact-checking team (4 full-time)
  3. 03

    Clinician re-review

    A board-certified MD or PhD from the 42-member Editorial Board signs off on the corrected wording. No correction ships without a clinical reviewer attached by name and credentials.

    Owner Editorial Board (rotating)
  4. 04

    Public log entry

    The original claim, corrected claim, the catcher, and the resolution timestamp are published here. The corrected article is republished with an inline banner linking back to this entry.

    Owner Standards Desk + Engineering

Weekly Brief

The same standard, delivered every Sunday.

612,000 readers get our Weekly Brief — physician-reviewed, citation-linked, with corrections surfaced inline when they happen. Five minutes to read. Built for the kind of person who reads a Corrections Log on purpose.

Free. No pharma ads. Unsubscribe in one click. Read by 612,000 subscribers with a 46% average open rate.

$8.4M In pharma and supplement advertising rejected since 2019 to preserve editorial independence
HONcode Certified since 2019, recertified every two years — one of 31 U.S. health sites with current certification
Sigma Awards 2024 Data-journalism prize for our supplement-industry trial-retraction investigation